174
O. Rosati et al.
4.21 (dd, J = 2.4, 12.1 Hz, 1H, H-6), 4.14 (ddd, J = 2.4,
5.5, 9.6 Hz, 1H, H-5), 3.84 (dt, J = 6.7, 9.8 Hz, 1H, H-10),
3.55 (dt, J = 6.7, 9.8 Hz, 1H, H-10), 2.17 (m, 2H, H-30),
2.15 (s, 3H, CH3), 2.12 (s, 3H, CH3), 1.74 (m, 2H, H-20).
GC–MS: m/z 298 [M?], 239, 225, 213,154, 111, 86.
Benzyl-2-deoxy-3,4,6-tri-O-acetyl-a/b-D-glucopyranoside
(Table 2, entry 5a—procedure 2) purification: SiO2 column
chromatoghraphy, eluent: Petroleum ether/Et2O 1:1, oil. 1H-
NMR (400 MHz, CDCl3) d(a anomer)7.4 (m, 5H, PhH), 5.38
(ddd, J = 5.4, 9.8, 11.4 Hz, 1H, H-3), 5.06 (m, 1H, H-1), 5.02
(t, J = 9.7 Hz, 1H, H-4), 4.68 (d, J = 12.0 Hz, 1H, HCH–
Ph), 4.52 (d, J = 12.0 Hz, 1H, HCH–Ph), 4.32 (dd, J = 5.3,
10.0 Hz, 1H, H-6a), 4.02 (m, 2H, H-5, H-6b), 2.29 (dd,
J = 5.4, 13.0 Hz, 1H, H-2 eq), 2.10 (s, 3H, CH3), 2.04 (s, 3H,
CH3), 2.01 (s, 3H, CH3), 1.86 (m, 1H, H-2ax). GC–MS: m/
z 379 [M?], 289, 273, 183, 153, 111, 91.
1H-NMR (400 MHz, CDCl3) d (b anomer) 7.4 (m, 5H,
PhH), 5.02–4.98 (m, 3H, H-1, H-3, H-4), 4.90 (d,
J = 12.0 Hz, 1H, HCH–Ph), 4.63 (d, J = 12.0 Hz, 1H,
HCH–Ph), 4.32 (m, 1H, H-6a), 4.16 (dd, J = 2.0, 12.0 Hz,
1H, H-6b), 3.61 (m, 1H, H-5), 2.35 (m, H-2eq), 2.10 (s, 3H,
CH3), 2.04 (s, 3H, CH3), 2.03 (s, 3H, CH3), 1.85–1.80 (m,
H-2ax).
(s, 3H, CH3), 2.04 (s, 3H, CH3), 2.07–2.01 (m, 1H, H-2ax),
1.47 (s, 9H, tBu).
40-(Tert-buthyl)phenil-2-deoxy-3,4,6-tri-O-acetyl-a/b-D-
galactopiranoside (Table 2, entry 6c—procedure 2), puri-
fication: SiO2 column chromatoghraphy, eluent: CH2Cl2/
Hexane 9:1, oil. 1H-NMR (400 MHz, CDCl3) d (a anomer)
7.33 (d, J = 9.0 Hz, 2H, PhH), 7.01 (d, J = 9.0 Hz, 2H,
PhH), 5.74 (d, J = 2.8 Hz, 1H, H-1), 5.53 (ddd, J = 3.1,
5.1, 12.4 Hz, 1H, H-3), 5.42 (d, J = 2.9 Hz, 1H, H-4), 4.29
(t, J = 6.7 Hz, 1H, H-5), 4.12 (dd, J = 6.1, 11.2 Hz, 1H,
H-6a,), 4.08 (dd, J = 7.1, 11.2 Hz, 1H, H-6b), 2.27 (m, 1H,
H-2eq), 2.18 (s, 3H, CH3), 2.12 (m, 1H, H-2ax), 2.05 (s, 3H,
CH3), 1.94 (s, 3H, CH3), 1.32 (s, 9H, tBu). GC–MS: m/
z 422 [M?], 362, 273, 213, 150, 135, 111.
1H-NMR (400 MHz, CDCl3) d (b anomer) 7.31 (d,
J = 9.0 Hz, 2H, PhH), 6.97 (d, J = 9.0 Hz, 2H, PhH),
5.34 (d, J = 2.9 Hz, 1H, H-4), 5.17 (dd, J = 2.6, 9.6 Hz,
1H, H-1), 5.11 (ddd, J = 3.12, 5.0, 12.2 Hz, 1H, H-3), 4.25
(dd, J = 7.0, 11.2 Hz, 1H, H-6a), 4.18 (dd, J = 6.2,
11.2 Hz, 1H, H-6b), 3.96 (bt, J = 6.3 Hz, 1H, H-5),
2.29–2.16 (m, 2H, H-2eq,ax), 2.12 (s, 3H, CH3), 2.07 (s, 3H,
CH3), 2.04 (s, 3H, CH3), 1.32 (s, 9H, tBu).
40-Hydroxyphenetyl-2-deoxy-3,4,6-tri-O-acetyl-a-D-gluco-
pyranoside(Table 2,entry7a—procedure 2)purification: SiO2
column chromatoghraphy, eluent: CH2Cl2/EtOAc 2:1, oil. 1H-
NMR (400 MHz, CDCl3)d(aanomer) 7.6 (d, J = 9.2 Hz, 2H,
PhH), 7.2 (d, J = 9.2 Hz, 2H, PhH), 5.27 (ddd, J = 5.3, 9.4,
11.6 Hz, 1H, H-3), 4.94 (d, J = 9.8 Hz, 1H, H-4), 4.91 (bd,
J = 2.8 Hz, 1H, H-1), 4.15 (dd, J = 4.3, 12.3 Hz, 1H, H-6a),
3.92 (dd, J = 2.3, 12.3 Hz, H-6b), 3.74 (m, 1H, O–HCH), 3.62
(m, 1H, O–HCH), 3.47 (ddd, J = 2.3, 4.2, 10.1 Hz, 1H, H-5),
2.81 (t, J = 6.7 Hz, 2H, CH2Ph), 2.23 (ddd, J = 1.1, 5.3,
12.9 Hz, 1H, H-2eq), 2.08, (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.02
(s, 3H, CH3), 1.78 (ddd, J = 3.6, 11.7, 12.8 Hz, 1H, H-2ax).
GC–MS: m/z 410 [M?], 273, 213, 120.
40-Hydroxyphenetyl-2-deoxy-3,4,6-tri-O-acetyl-a-D-galac-
topyranoside (Table 2, entry 7c—procedure 2), purification:
SiO2 column chromatoghraphy, eluent CH2Cl2/EtOAc 9:1, oil.
1H-NMR (400 MHz, CDCl3) d 7.10 (d, J = 9.0 Hz, 2H, PhH),
6.79 (d, J = 9.0 Hz, 2H, Ph–H a,b), 5.26 (m, 2H, H-3, H-4),
4.99 (d, J = 2.6 Hz, 1H, H-1), 4.00 (d, J = 6.8 Hz, 2H,
H-6a,b), 3.77 (m, 1H, O–HCH), 3.70 (bt, J = 6.6 Hz, 1H, H-5),
3.63 (m, 1H, O–HCH), 2.82 (t, J = 7.6 Hz, 2H, PhCH2 b), 2.09
(m, H-2eq), 2.13 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.01 (s, 3H,
CH3), 1.86 (m, H-2ax).
Benzyl-2-deoxy-3,4,6-tri-O-acetyl-a-D-galactopirano-
side (Table 1, entry 4c; Table 2, entry 5c—procedure 2)
purification: SiO2 column chromatography, eluent:
1
CH2Cl2/EtOAc 9:1. H-NMR (400 MHz, CDCl3) d 7.36
(m, 5H, PhH), 5.37 (d, J = 2.6 Hz, 1H, H-4), 5.33 (m, 1H,
H-3), 5.12 (d, J = 3.0 Hz, 1H, H-1), 4.71 (d, J = 11.8 Hz,
1H, HCH–Ph), 4.52 (d, J = 11.8 Hz, 1H, HCH–Ph), 4.22
(m, 1H, H-5), 4.11 (m, 2H, H-6), 2.15 (s, 3H, CH3), 2.10 (m,
1H, H-2eq), 2.07 (s, 3H, CH3), 1.99 (s, 3H, CH3), 1.93 (m,
1H, H-2ax). GC–MS: m/z 379 [M?], 320, 289, 273,
213,153.
40-(Tert-buthyl)phenyl-2-deoxy-3,4,6-tri-O-acetyl-a/b-D-
glucopyranoside (Table 2, entry 6a—procedure 2), purifi-
cation: SiO2 column chromatoghraphy, eluent: Hexane/
EtOAc 3:1, oil. 1H-NMR (400 MHz, CDCl3) d (a anomer)
7.65 (d, J = 9.1 Hz, 2H, PhH), 7.10 (d, J = 9.1 Hz, 2H,
PhH), 5.67 (d, J = 2.28 Hz, 1H, H-1), 5.55 (ddd, J = 5.4,
9.5, 11.6 Hz, 1H, H-3), 5.11 (t, J = 9.8 Hz, 1H, H-4), 4.31
(dd, J = 4.5, 12.2 Hz, 1H, H-6a), 4.09 (ddd, J = 2.0, 4.5,
10.2 Hz, 1H, H-5), 4.02 (dd, J = 2.1, 12.2 Hz, 1H, H-6b),
2.47 (ddd, J = 0.8, 5.3, 13.0 Hz, 1H, H-2eq), 2. 80 (s, 3H,
CH3), 2.07 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.01 (ddd,
J = 3.6, 11.8, 13.0 Hz, 1H, H-2ax), 1.47 (s, 9H, tBu). GC–
MS: m/z 422 [M?], 289, 213, 153.
Cyclohexylmethyl-2-deoxy-3,4,6-tri-O-benzyl-a-D-galacto-
pyranoside (Table 3, entry 1b—procedure 2) purification:
SiO2, column chromatoghrapy, eluent: Petroleum ether/
EtOAc 8:2, yellow oil. 1H-NMR (400 MHz, CDCl3) d 7.33
(m, 15H, PhH), 4.95 (m, 2H, H-1, HCH–Ph), 4.64 (m, 3H,
Benzylic), 4.54 (d, J = 11.7 Hz, 1H, O–HCH–Ph), 4.45 (d,
J = 11.7 Hz, 1H, O–HCH–Ph), 3.94 (m, 3H, H-3, H-4,
H-5), 3.61 (m, 2H, H-6a,b), 3.43 (dd, J = 7.2, 9.5 Hz, 1H,
1H-NMR (400 MHz, CDCl3) d (b anomer) 7.55 (d,
J = 9.0 Hz, 2H, PhH), 6.95 (d, J = 9.0 Hz, 2H, PhH),
5.18 (dd, J = 2.2, 9.6 Hz, 1H, H-1), 5.41–5.50 (m, 2H,
H-3, H-4), 4.30 (m, 1H, H-6a), 4.16 (dd, J = 2.5, 12.1 Hz,
H-6b), 3.76 (ddd, J = 2.5, 9.2, 5.5 Hz, 1H, H-5), 2.52 (dd,
J = 2.0, 4.8, 12.4 Hz, 1H, H-2eq), 2.06 (s, 3H, CH3), 2.05
123